Cart
sales@molnova.com
ALOIN (b)
CAS No. 8015-61-0
ALOIN (b)( —— )
Catalog No. M20358 CAS No. 8015-61-0
ALOIN Inhibits Interleukin (IL)-1β-Stimulated IL-8 Production in KB Cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 84 | In Stock |
|
| 10MG | 116 | In Stock |
|
| 25MG | 187 | In Stock |
|
| 50MG | 259 | In Stock |
|
| 100MG | 361 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameALOIN (b)
-
NoteResearch use only, not for human use.
-
Brief DescriptionALOIN Inhibits Interleukin (IL)-1β-Stimulated IL-8 Production in KB Cells.
-
DescriptionALOIN Inhibits Interleukin (IL)-1β-Stimulated IL-8 Production in KB Cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetMMP
-
RecptorMMP|IL Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number8015-61-0
-
Formula Weight418.39
-
Molecular FormulaC21H22O9?
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (239.01 mM)
-
SMILES[H][C@@]1([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2cccc(O)c2C(=O)c2c(O)cc(CO)cc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Barrantes E Guinea M . Inhibition of collagenase and metalloproteinases by aloins and aloe gel[J]. Life Sciences 2003 72(7):0-850.
molnova catalog
related products
-
Andecaliximab
Andecaliximab is a recombinant IgG4 monoclonal antibody targeting matrix metalloproteinase 9 (MMP9). Andecaliximab showed antifibrotic effects in a mouse model of idiopathic pulmonary fibrosis.
-
S-methyl-KE-298
S-methyl-KE-298 is the second main metabolite in plasma,is a methyl conjugate of deacetyl-KE-298.KE-298 inhibits matrix metalloproteinase (MMP-1) production from ?rheumatoid arthritis (RA) synovial cells.
-
PD-166793
PD-166793 is an orally active, potent and selective MMP inhibitor with inhibitory effects on MMP-2, MMP-3 and MMP-13.PD-166793 ameliorates myocardial ischemia and reperfusion injury in a rat model of heart failure.
